Can the AIDS Pandemic be Curtailed Through the Use of Current HIV Vaccines and Highly Active Antiviral Therapies?

JUN 10 '97 11:49AM AAAS SCIENCE MAGAZINE
ROM: Mullins Lab - UWJ
4

JUN. 3. 1997 Vc,r1 r
PHNE NO.: 1611 8 '

MuWns, Page 4
1. S. P. Mossman, et al., J. Virology 70,1953-1960 (1996).
2. S. Lu, et al., J. Virology 70, 3978-3991 (1996).
3. Z. R. Israel, et al., J. Virol. 66,1843-1853 (1994).
4. L D. Giavedoni, et al., J Viral 67, 577-83 (1993).
5. 8. Ahtad, et al., AIDS Res. Hum. Retroviruses 10,195-204 (1994).
6. C. Bruck, et al., Vaccine 12,1141-1148 (1994).
7. J.W. Mellors, et al., Science 272,1167-1170 (1996).
8. R. E. Dickover, et al., Jama. 28. 275, 599-605. (1996).
9. 8. Weiser, et al., Proceedings of the National Academy of Sciences 91, 8037-8041
(1994).
10. Y. Cao, et al., Nature Med. 3, 549"552 (1997).
11. W.T. Shearer, et al., New Eng. i. Med. 336, 1337-1342 (1997).
12. V. M. Hirsch, et at, J Viral 70, 3741-52 (1996).
13. I. M. Longini, Jr., S. Dat ta, M. E. Halloran, I. Acquir. Immune. Defic. Syndr. Hum.
Retrovi ol. 13, 440-447 (1996).
14. J. S. Koopman, R. I. Little, Am. I. Epidem. 142, 1113-1120 (1995).